​

Lantheus (LNTH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LNTH Stock Forecast

Lantheus (LNTH) stock forecast, based on 17 Wall Street analysts, predicts a 12-month average price target of $79.33, with a high of $89.00 and a low of $72.00. This represents a -1.36% decline from the last price of $80.42.

$60 $70 $80 $90 $100 $110 High: $89 Avg: $79.33 Low: $72 Last Closed Price: $80.42

LNTH Stock Rating

Lantheus stock's rating consensus is Buy, based on 17 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (76.47%), 4 Hold (23.53%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 17 0 4 13 Strong Sell Sell Hold Buy Strong Buy

LNTH Price Target Upside V Benchmarks

TypeNameUpside
StockLantheus-1.36%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks25.21%

Price Target Trends

1M3M12M
# Anlaysts136
Avg Price Target$89.00$81.00$77.17
Last Closing Price$80.42$80.42$80.42
Upside/Downside10.67%0.72%-4.04%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26292--13
Feb, 26292--13
Jan, 26292--13
Dec, 25283--13
Nov, 25283--13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 27, 2026Richard NewitterTruist Financial$89.00$74.9118.81%10.67%
Dec 18, 2025Truist Financial$82.00$65.3525.48%1.96%
Dec 17, 2025Mizuho Securities$72.00$65.1710.48%-10.47%
Dec 11, 2025Richard NewitterTruist Financial$80.00$63.0926.80%-0.52%
Oct 08, 2025Goldman Sachs$77.00$51.8448.53%-4.25%
Aug 11, 2025Richard NewitterTruist Financial$63.00$56.0712.36%-21.66%
Dec 18, 2024Paul ChoiGoldman Sachs$143.00$91.1556.88%77.82%
Sep 03, 2024Ed Ridley-DayRedburn Partners$175.00$106.4764.37%117.61%
Aug 01, 2024David TurkalyJMP Securities$125.00$104.8319.24%55.43%
Jul 12, 2024Anthony PetroneMizuho Securities$165.00$123.6233.47%105.17%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 27, 2026Seaport GlobalNeutralupgrade
Feb 26, 2026William BlairOutperformupgrade
Feb 24, 2026CitigroupOutperformOutperformhold
Oct 08, 2025Goldman SachsBuyNeutraldowngrade
Dec 18, 2024Goldman SachsBuyBuyinitialise
Sep 16, 2024Cowen & Co.BuyBuyhold
Aug 01, 2024JMP SecuritiesOutperformOutperformhold
Jul 25, 2024B. RileyBuyBuyhold
Jul 10, 2024JMP SecuritiesOutperformOutperformhold
May 03, 2024Mizuho SecuritiesUnderperformUnderperformhold

Financial Forecast

EPS Forecast

$-5 $-1 $3 $7 $11 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.06$0.41$4.79$4.52$3.46---
Avg Forecast$0.41$3.84$5.92$6.74$7.01$7.82$8.73$11.28
High Forecast$0.44$4.10$6.01$6.94$7.66$9.11$10.70$12.41
Low Forecast$0.40$3.67$5.79$6.65$6.52$6.52$7.34$10.57
Surprise %-358.54%-89.32%-19.09%-32.94%-50.64%---

Revenue Forecast

$0 $600M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$425.21M$935.06M$1.30B$1.53B$1.54B---
Avg Forecast$407.40M$916.62M$1.28B$1.52B$1.61B$1.81B$2.10B$2.52B
High Forecast$426.48M$966.08M$1.29B$1.54B$1.73B$1.82B$2.10B$2.71B
Low Forecast$395.37M$887.05M$1.27B$1.51B$1.53B$1.81B$2.09B$2.40B
Surprise %4.37%2.01%1.13%0.88%-4.21%---

Net Income Forecast

$-100M $100M $300M $500M $700M $900M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-71.28M$28.07M$326.66M$312.44M$233.56M---
Avg Forecast$6.98M$33.67M$326.66M$477.52M$498.28M$517.16M$655.29M$792.30M
High Forecast$28.28M$55.24M$585.46M$487.68M$538.30M$639.92M$751.74M$871.79M
Low Forecast$-14.33M$12.11M$67.86M$467.36M$458.27M$458.12M$515.43M$742.59M
Surprise %-1121.86%-16.65%--34.57%-53.13%---

LNTH Forecast FAQ

Is Lantheus stock a buy?

Lantheus stock has a consensus rating of Buy, based on 17 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Lantheus is a favorable investment for most analysts.

What is Lantheus's price target?

Lantheus's price target, set by 17 Wall Street analysts, averages $79.33 over the next 12 months. The price target range spans from $72 at the low end to $89 at the high end, suggesting a potential -1.36% change from the previous closing price of $80.42.

How does Lantheus stock forecast compare to its benchmarks?

Lantheus's stock forecast shows a -1.36% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (25.21%).

What is the breakdown of analyst ratings for Lantheus over the past three months?

  • March 2026: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.

What is Lantheus’s EPS forecast?

Lantheus's average annual EPS forecast for its fiscal year ending in December 2026 is $7.82, marking a 126.01% increase from the reported $3.46 in 2025. Estimates for the following years are $8.73 in 2027, and $11.28 in 2028.

What is Lantheus’s revenue forecast?

Lantheus's average annual revenue forecast for its fiscal year ending in December 2026 is $1.81B, reflecting a 17.62% increase from the reported $1.54B in 2025. The forecast for 2027 is $2.1B, and $2.52B for 2028.

What is Lantheus’s net income forecast?

Lantheus's net income forecast for the fiscal year ending in December 2026 stands at $517.16M, representing an 121.42% increase from the reported $233.56M in 2025. Projections indicate $655.3M in 2027, and $792.3M in 2028.